Wolverine Trading
IOVA icon

Wolverine Trading’s Iovance Biotherapeutics IOVA Stock Holding History

Wolverine Trading’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$470K Buy
+210,800
New +$498K ﹤0.01% 3782
2025
Q2 		– Sell
-112,100
Closed -$399K – 5159
2025
Q1 		$399K Buy
112,100
+46,300
+70% +$239K ﹤0.01% 3216
2024
Q4 		$472K Buy
65,800
+22,000
+50% +$204K ﹤0.01% 3454
2024
Q3 		$421K Sell
43,800
-11,700
-21% -$111K ﹤0.01% 3241
2024
Q2 		$445K Sell
55,500
-62,000
-53% -$664K ﹤0.01% 2954
2024
Q1 		$1.74M Sell
117,500
-177,500
-60% -$2.07M ﹤0.01% 1710
2023
Q4 		$2.4M Buy
295,000
+83,400
+39% +$436K ﹤0.01% 1577
2023
Q3 		$963K Buy
211,600
+58,000
+38% +$379K ﹤0.01% 2136
2023
Q2 		$1.08M Buy
153,600
+13,100
+9% +$93.8K ﹤0.01% 1948
2023
Q1 		$864K Buy
140,500
+72,600
+107% +$501K ﹤0.01% 2025
2022
Q4 		$434K Buy
67,900
+10,700
+19% +$83.5K ﹤0.01% 2454
2022
Q3 		$545K Sell
57,200
-31,400
-35% -$362K ﹤0.01% 2528
2022
Q2 		$965K Buy
88,600
+38,500
+77% +$505K ﹤0.01% 1957
2022
Q1 		$837K Buy
50,100
+3,000
+6% +$46.4K ﹤0.01% 2639
2021
Q4 		$915K Sell
47,100
-8,000
-15% -$176K ﹤0.01% 2743
2021
Q3 		$1.31M Sell
55,100
-33,200
-38% -$782K ﹤0.01% 2640
2021
Q2 		$2.33M Buy
+88,300
New +$2.3M ﹤0.01% 1830

Other funds holding IOVA

MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wolverine Trading's IOVA Position: Q3 2025 in Review

Wolverine Trading opened a new position in Iovance Biotherapeutics (IOVA) in Q3 2025: 21,739 shares worth $48.5K. The stake represents ﹤0.01% of the portfolio and ranks #5418 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in IOVA as recently as Q1 2025.

Wolverine Trading first reported a position in IOVA in Q2 2021 and has held it in 15 quarters since. The position peaked at $993K in Q4 2023. 253 funds tracked by Wall St. Rank hold IOVA as of Q3 2025.

  • Wolverine Trading held 21,739 shares of Iovance Biotherapeutics worth $48.5K as of Q3 2025.
  • Iovance Biotherapeutics was a new Wolverine Trading position in Q3 2025.
  • Iovance Biotherapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5418 holding.
  • Wolverine Trading first reported a position in Iovance Biotherapeutics in Q2 2021 and has held it in 15 quarters since.
  • Wolverine Trading's Iovance Biotherapeutics position peaked at $993K in Q4 2023.
  • 253 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.